home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences
Search  -  prev / next
 
 

Advancing Precision Oncology with Biomarker-driven Strategies and Digital Data Solutions

 
  July 24, 2026  
     
 


Xtalks — The Life Science Community™, Online webinar
2026-08-20


Precision oncology is transforming cancer care by enabling therapies to be matched to the molecular characteristics of individual patients. As biomarker-driven development expands across tumor types, sponsors face increasing challenges in identifying eligible patients, optimizing trial execution and generating the evidence needed to support regulatory, reimbursement and clinical decision-making. This webinar will explore strategies for advancing precision oncology across the development lifecycle. Topics will include the evolving biomarker landscape and testing approaches, innovative methods for identifying and recruiting biomarker-eligible patients through decentralized and hybrid trial models and the growing role of high-quality clinical data and real-world evidence in accelerating development and demonstrating value. The discussion will also highlight how AI-enabled data extraction, linked clinical and genomic datasets and modern evidence-generation strategies are helping sponsors gain deeper insights, improve trial efficiency and support broader adoption of precision therapies. Register for this webinar to learn how precision oncology strategies can strengthen biomarker-driven patient identification, trial execution and evidence generation.
 
 
Organized by: Xtalks — The Life Science Community™
Invited Speakers:

Mark Yates, MD, PhD, Director of RWE Strategy and RWD Solutions, PPD clinical research business, Thermo Fisher Scientific

Jai Balkissoon, MD, FACS, Global Vice President, Head Cell and Gene Therapy, Medical Science & Strategy, Oncology, PPD, clinical research business, Thermo Fisher Scientific

Ethel Pilati, Executive Director, Project Management, Precision Medicine in Oncology, Lead, PPD clinical research business, Thermo Fisher Scientific

Anu Bansal, MD, MS, VP, Head of Oncology, Medical Imaging, Endpoint Data, CLARIO, part of Thermo Fisher Scientific

Jane Li, Senior Director, Pharma and CRO, Life Sciences Solutions, Thermo Fisher Scientific

Yarden Ginsburg, Senior Patient Recruitment & Engagement Lead, Patient First Digital Solutions, PPD Clinical Research Services, Thermo Fisher Scientific

 
Deadline for Abstracts: 2026-08-20
 
Registration:

https://xtalks.com/webinars/advancing-precision-oncology-with-biomarker-driven-strategies-and-digital-data-solutions/

E-mail: clientservices@xtalks.com
 
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2026 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.